LYEL Sale Disclosure
Seely Lynn · SEC Form 4 · Filed Aug 11, 2026
Sale
Calculated transaction value
$5.59K
Seely Lynn President And CEO
LYEL
Lyell Immunopharma
LYEL
Transaction date
Aug 10, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 1 day later
LYEL daily price context
Close on/before transaction
$14.33
Aug 10, 2026
Close before public filing
$14.33
Aug 10, 2026
Return since public filing
-25.02%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 390 shares @ $14.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001327111-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$5.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | Aug 10, 2026 | $5.59K |